◆ 会议时间:2025年5月7-10日
◆ 会议地点:美国 路易斯维尔市
◆ 会议简介:
2025年美国儿科血液学肿瘤学会(ASPHO)年会将于2025年5月7-10日在美国肯塔基州路易斯维尔市举行。ASPHO年会是儿科血液学肿瘤学领域首屈一指的学术会议,不仅为与会者提供高质量的教育内容,同时也是与同行建立联系,分享交流该领域创新进展的平台。预计有来自世界各地的1200余名专业人士与会。
美国儿科血液学肿瘤学会(ASPHO)成立于1981年,现拥有2000余名会员,ASPHO是唯一致力于宣促进儿科血液学/肿瘤学专科医生专业发展和兴趣的专业组织。ASPHO是一个多学科组织,通过推进研究、教育、治疗和专业实践,对患有血液疾病和癌症的儿童和青少年提供最佳的护理。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)。
ASPHO 2025 - American Society of Pediatric Hematology/Oncology Conference
Date: May 7-10, 2025
Venue: Kentucky International Convention Center, Louisville, KY, USA
More than 1,200 pediatric hematology/oncology professionals from around the world attend the ASPHO Conference. A flagship meeting for the field, the ASPHO Conference allows attendees to receive high-quality educational content, network with their colleagues, and discover innovative advancements in pediatric hematology/oncology.
Attendees receive superior educational programming from internationally known experts in the field of pediatric hematology/oncology. The educational programming includes a dynamic variety of symposia, workshops, plenary sessions, and poster sessions.
重要日期:
2025 Call for Workshops
April 22 - July 25, 2024
2025 Call for Abstracts
October - December 19, 2024
2025 Call for Late-Breaking Abstracts
January 2 - January 30, 2025
点此提交摘要>>>Submit Abstract>>>
General Information
- All communication will go to the Submitter.
- Abstracts are limited to 400 words. Tables and charts will not be accepted.
- All submitters (including those who submit case reports/series) must include the following components in the body of the abstract:
- Background
- Objective
- Design/Method
- Results
- Conclusion
- Submitters must indicate the institution, city, state and country where the research was done.
- Each abstract (including case reports/case series) must have a theme or topic selected.
- Hemostasis, Thrombosis, and Vascular Biology
- Hemoglobinopathies
- General Hematology
- Leukemia/Lymphoma/Histiocyte Disorders
- Solid Tumors
- General Oncology
- Hematopoietic Stem Cell Transplantation and Cellular Therapy
- Outcomes Research
- Quality Improvement/Patient Safety
- Mark whether your abstract is a case report/case series (a case report/case series is defined as a study that includes 5 or less subjects)
- All case reports must include at least some data, otherwise, the abstract will be rejected.
- Submitters should also indicate:
- If they will be applying for the ASPHO Young Investigator Award, the Early Career Travel Stipend Award, or the Advanced Practice Provider Award.
- Their preferred presentation format: oral, poster, or both.
- If the abstract was accepted at any other national meeting(s).
All accepted abstracts will be published on the ASPHO website and in the Pediatric Blood & Cancer Journal (online format) as submitted. ASPHO will not allow any changes to the abstract once the system closes on December 19, 2024.
Conference Registration Guidelines for Presenters:
Paper and poster abstracts will be presented during concurrent session time blocks throughout the Conference. Papers will be presented on Wednesday, May 7, Thursday, May 8, and Friday, May 9, and posters will be presented on Thursday, May 8 and Friday, May 9. Presentation times will be assigned at the time the abstract is accepted; authors cannot request a specific presentation date/time. Prior to submission of a paper or poster, at least one author must agree to attend the ASPHO meeting and to participate live in-person as the paper or poster presenter. Presenters are responsible for all personal expenses (e.g., travel, hotel) and for conference registration fees. ASPHO will not waive the registration fee for presenters and conference registration is required. Presenters are encouraged to register for the meeting and to reserve hotel accommodations as early as possible to ensure that space is available.
Submission
The system will remain open until 3:00 pm Central Time (4:00 pm Eastern Time; 2:00 pm Mountain Time; 1:00 pm Pacific Time) on Thursday, December 19, 2024.
Fee
There will be a $30.00 USD fee per abstract to be paid by credit card. The fee will be collected at the end of the submission process, before the abstract can be submitted. Payment must be done online within the system during the time of submission (payment will not be taken in any other form such as by phone or check). NOTE: Your submission will not be considered 'complete' until the payment is processed and the abstract is submitted, so please take this step into consideration when you submit your proposal.
Notification
Submitters will be notified by the end of March 19, 2025 regarding selection of their abstract.
Late-Breaking Abstracts
In an effort to increase and highlight the amount of cutting-edge science presented at the ASPHO Conference and to recognize novel, critically important research developments that may occur after the general abstract submission deadline, ASPHO will hold a call for late-breaking abstract submissions for presentation at the 2025 Conference. The call will be open January 2 – 30, 2025. If your research results are not available by the general abstract submission deadline (December 19, 2024), consider submitting an abstract for the late-breaking call. More information and a separate, late-breaking submission link will be available at the beginning of January. Submitting a place-holder abstract during the general call for abstracts is not required.
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|